What Bad Facial Plastic Surgery Means for Patients and Costs
Bad facial plastic surgery refers to procedures that result in complications, asymmetry, scarring, or functional issues requiring revision or correction. The American Society of Plastic Surgeons reports that revision rhinoplasty and facelift corrections represent a meaningful share of secondary procedures, with costs often exceeding the original surgery. Patients typically face additional surgeon fees, anesthesia, and facility charges when outcomes are unsatisfactory or medically problematic.
According to data from the American Society of Plastic Surgeons and industry cost analyses, revision rates and out-of-pocket expenses vary by procedure type and surgeon qualifications. For example, rhinoplasty revisions can cost tens of thousands of dollars, while scar revision or fat grafting corrections add further financial burden. These figures are widely cited in health economics discussions and patient advocacy resources.
Common Complications and Clinical Outcomes in Facial Procedures
Facial procedures carry documented risks including infection, nerve injury, hematoma, and unfavorable scarring. The U.S. Food and Drug Administration tracks device-related adverse events, and the American Society of Plastic Surgeons publishes outcome data that highlights complication rates for facelifts, rhinoplasty, and eyelid surgery. Patient satisfaction surveys show that botched results correlate strongly with board certification status and facility accreditation.
Clinical guidelines emphasize that infection rates and revision needs decrease when surgeons operate in accredited facilities and use FDA-cleared implants and injectables. Bad outcomes often stem from unqualified providers, non-accredited clinics, or off-label product use. The FDA and professional societies provide safety alerts and device summaries that help patients evaluate risk.
Regulation, Legal Recourse, and Industry Oversight
Board certification by the American Board of Plastic Surgery remains a key indicator of training and adherence to safety standards. State medical boards license surgeons and investigate complaints, while the FDA oversees devices and injectables used in facial procedures. Patients who experience bad results may pursue malpractice claims, and court records show settlement trends tied to revision surgery and documented harm.
The SEC and public company filings from medical device manufacturers disclose product performance and litigation exposure related to facial implants and fillers. Industry rankings from organizations such as the American Society of Plastic Surgeons help consumers compare surgeon credentials and outcomes. Regulatory updates and safety communications from the FDA provide current guidance on device recalls and adverse event reporting.